903 Phase I trial of tandem intravenous and intraperitoneal delivery of IL-12 armored CAR T cells targeting MUC16 in patients with recurrent high-grade serous ovarian cancer
Poster and E-Posters（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要